Robert Berman, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 70,963 shares at $37.07 ($2.6M) on 2018-06-12, disclosed to the SEC on 2018-06-20.
Open-market sale of $2.6M BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.25 | 4,409 | $155K | 6.0% |
| 2 | $36.15 | 55,907 | $2.0M | 78.6% |
| 3 | $37.07 | 10,647 | $395K | 15.4% |
| Total | $36.23 avg | 70,963 | $2.6M | 100% |
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $13.3M | — | Filing → |
| BHVN | BUY | 2019-06-28 | $106K | — | Filing → |